Antidepressant use during early pregnancy and the risk of congenital anomalies.
about
The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study.Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats.Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.Perinatal depression: A clinical update.Antidepressant exposure in pregnancy and risk of autism spectrum disorders.Use of selective serotonin-reuptake inhibitors in the first trimester and risk of cardiovascular-related malformations: a meta-analysis of cohort studies.Tricyclic antidepressants in pregnancy and puerperium.Selective serotonin reuptake inhibitors and risk of major congenital anomalies for pregnancies in Japan: A nationwide birth cohort study of the Japan Environment and Children's Study.Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study.Antenatal Exposure and Diseases in the Offspring: The Role of Big Data.Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million birthsMaternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring
P2860
Q26741187-9410C0BD-A21E-4FC0-B67A-BDAA04096B01Q34516341-44F876F3-D168-4EEE-AFB2-E7169624D40DQ34714284-B7803A65-CDA7-4292-B949-B4CE0F22FE86Q35541040-A221C8D2-70E8-498D-A5CA-57DB2C2CA4CEQ36706789-A320B566-4769-4364-B43B-EAE098228E55Q36826240-C50317CA-2CDB-4C56-A2C8-3540BA86A51BQ37320948-C7A3FF87-8749-4A0F-B3FA-B9BFFEB674C3Q37654878-6C3B249D-8728-4386-95A7-45D89A5EB2AEQ38175172-B7585AAC-66C7-4B00-B85E-915C299251CAQ39160045-424AB4E5-4DF5-4CE5-A5F6-6B3A7CB18DA7Q40764468-BAEAF798-7860-4FA7-A22E-F6BAB7125E5CQ43557393-E045359B-EA96-471A-A37A-3C994E58DFBAQ59129888-6CA6C880-AFB2-4808-AD54-B8558F273FC0Q59135191-B7601C37-E688-4892-93B8-B10E720BC706
P2860
Antidepressant use during early pregnancy and the risk of congenital anomalies.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Antidepressant use during early pregnancy and the risk of congenital anomalies.
@en
Antidepressant use during early pregnancy and the risk of congenital anomalies.
@nl
type
label
Antidepressant use during early pregnancy and the risk of congenital anomalies.
@en
Antidepressant use during early pregnancy and the risk of congenital anomalies.
@nl
prefLabel
Antidepressant use during early pregnancy and the risk of congenital anomalies.
@en
Antidepressant use during early pregnancy and the risk of congenital anomalies.
@nl
P2860
P50
P356
P1433
P1476
Antidepressant use during early pregnancy and the risk of congenital anomalies.
@en
P2093
Catherine Vasilakis-Scaramozza
P2860
P304
P356
10.1002/PHAR.1211
P407
P577
2013-06-06T00:00:00Z